Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium PharmaceuticalsCambridge, UK, 12 March 2025:&
Gyles Brandreth urges public to Support CBM UK’s World in Focus Campaign to end avoidable sight loss
Broadcaster and writer Gyles Brandreth is lending his passionate support to Cambridge based, Global Disability Inclusion charity, CBM UK’s World in Focus campaign, highlighting the urgent need to tackle avoidable sight loss affecting 1.1 billion people worldwide.
Two Milner Institute bio-incubator companies win cofinitive #21toWatch awards
Two companies based at the Milner Therapeutics Institute bio-incubator have won Cofinitive #21toWatch awards.
Highlights from another great year for Cambridge Enterprise
The Cambridge Enterprise Annual Review 2024 showcases how the commercialisation of groundbreaking research creates tangible societal benefits.
Trainee surgeon scoops coveted award
An Addenbrooke’s doctor who is in the final stages of training to become a vascular surgeon has been given a prestigious award for her research.
25 years of Guardtech: the past, present and future as told by their founder
The Suffolk contamination control specialists constructed their first ever cleanroom 25 years ago – Director and founder Ray Wheeler explains how we became the business we are today
Biotech dominates at 2025 #21toWatch Awards with winners focused on remedying persisting medical challenges
The #21toWatch Top21.2025 winners have been announced at an inspirational awards ceremony at The Glasshouse innovation hub in Cambridge.
Five Alarm Bio and Proteotype collaborate on new anti-aging approach
Five Alarm Bio Ltd and Proteotype Diagnostics Ltd have been awarded a highly-competitive collaborative grant from the Babraham Research Campus from the Campus Innovation Award programme, to develop and test novel biomarkers for cellular senescence.
Wilson Connectivity: Expanding the reach of wireless solutions with private 5G and enterprise-grade coverage
Connectivity really embodies what we’re about and we’re about connecting everyone, everywhere.” says Bruce Lancaster, CEO of Wilson Connectivity.
From Wilson Electronics to Wilson Connectivity: A Broader Vision
Breathing easier: tackling Alzheimer's through respiratory insights
At electronRx, we are constantly looking for ways we can leverage cutting-edge technology to redefine healthcare. We are excited about the potential of our work in pulmonary function and its connection to neurodegenerative diseases like Alzheimer's.
New insights into ageing revealed
The way in which blood stem cells evolve over a lifespan differs greatly between humans and mice, new research reveals. The findings provide a new understanding of the critical factors that influence tissue ageing.
OBN invites life science R&D companies, industry leaders, academics, and investors to BioTrinity 2025
Opening keynote from Tim Haines, Executive Partner at Abingworth, to provide a review of the life science investment landscapeExpected to welcome c900 delegates [SB1] spanning early-stage life science R&D,
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining Investment will support further development of CNS penetrant therapeutics based on the Company’s TRIMTACTM
Why family businesses are flourishing in Italy
In Luciana's March newsletter, she delves into some interesting research which reveals how and why innovative Italian family businesses are delivering economic growth 📈
Mestag Therapeutics appoints Dr. Matthew Sleeman as Chief Scientific Officer
Mestag Therapeutics, a biotech company harnessing fibroblast immunology for the benefit of patients with inflammatory disease and cancer, announces that Matthew Sleeman, PhD, has been appointed Chief Scientific Officer.
The life sciences sector: a model for collaboration
In today’s interconnected world, collaboration across borders is essential for addressing global challenges. The life sciences sector offers a compelling example of how nations can work together to foster innovation and mutual benefit.
Cambridge Festival showcases pioneering health research and innovations in medicine
The Cambridge Festival is returning from March 19 to April 4 with a series of events that bring together cutting-edge health research and the latest innovations in medical science.
Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections
Lead candidate in the ABX-01 programme to progress into first-in-human clinical studies Programme designed to treat Gram-negative bacterial lung infections in the most vulnerable patientsLondon, UK, 4 March 2025: Centauri Therapeu
FairJourney Biologics acquires Charles River Laboratories South San Francisco facility
Acquisition of Charles River site, previously Distributed Bio, strengthens antibody discovery capabilities with SuperHuman libraries and Yeast Display platformEstablished presence in major North American biotechnology cluster extends FairJourney’s global reach
Cambridge Campus Post-16 & Adults Jobs Fair
We’re Exhibiting at the 2025 Apprenticeships, Jobs & Careers Fair!Zinwave is excited to be part of the Cambridge Campus Post-16 & Adults Jobs Fair on Tuesday, March 4th, 2025, during National Careers Week!Looking for a career in cutting-edge wireless technology?
Why regional hubs are critical to biotech success - The next biotech breakthrough won’t happen in isolation
The biotech sector is pivotal in innovation and scientific advancement and is going from strength-to-strength. But often for start-ups in this space, success comes down to more than just breakthrough science. It’s also about location, collaboration, and the resources to scale innovation effectively.
10 existential hacks: Make your future the best thing that will ever happen to you
Møller Institute associate, Stephen Bruyant-Langer, reveals his top 10 hacks for dealing with uncertainty, in an increasingly unstable global climate. Stephen as a top executive coach, head-hunter, economist, marketeer, author, lecturer, facilitator and keynote speaker – comes with 25 years of experience with executive coaching, 20 years of experience with executive search, and 15 years of…
Guardtech Group set for expo treble, careers fair and awards showpiece in mega March
The Haverhill contamination control specialists will be appearing at two Space exhibitions in consecutive weeks as trade show season ramps up
AI matches the accuracy of expert radiologists to detect prostate cancer in a major multi-centre clinical study
Lucida Medical and Hampshire Hospitals NHS Foundation Trust announce the results of a 5-year collaboration. The PAIR-1 study shows that the Pi AI software, now in use in NHS and European hospitals, is the first commercial product of its kind with performance equivalent to that of expert radiologists to detect prostate cancer, the most common cancer in men.
